# Single Dose CHG Pharmacokinetic Study

> **NCT03331263** · PHASE1 · COMPLETED · sponsor: **Medline Industries** · enrollment: 12 (actual)

## Conditions studied

- Surgical Skin Preparation

## Interventions

- **DRUG:** Chlorhexidine Gluconate

## Key facts

- **NCT ID:** NCT03331263
- **Lead sponsor:** Medline Industries
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2017-08-06
- **Final completion:** 2017-08-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03331263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03331263, "Single Dose CHG Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03331263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*